Literature DB >> 10491055

Successful treatment of spider leg veins with a high-energy, long-pulse, frequency-doubled neodymium:YAG laser (HELP-G)

R A Massey1, B E Katz.   

Abstract

BACKGROUND: While sclerotherapy has been the standard treatment for spider leg veins for many years, recent advances have allowed lasers to be considered as a treatment option.
OBJECTIVE: To study the efficacy of a frequency-doubled Nd:YAG laser at 532 nm with a 50 ms pulse width and chill tip device in the treatment of spider leg veins.
METHODS: Forty-six patients with spider leg veins with a diameter of less than 1 mm or 1-2 mm were treated with a frequency-doubled Nd:YAG laser at 532 nm with a pulse width of 50 ms (VersaPulse HELP-G laser) while using a water-cooled chill tip device.
RESULTS: Of patients with veins less than 1 mm in diameter, 60% had greater than 50% clearing after one treatment and 80% had greater than 50% clearing after two treatments. Of patients with veins 1-2 mm in diameter, 39% achieved greater than 50% clearing after one treatment and 67% had greater than 50% clearing after two sessions.
CONCLUSION: Our results suggest that the frequency-doubled Nd:YAG laser with a pulse width of 50 ms and chill tip device offers an excellent alternative to sclerotherapy in the treatment of small spider leg veins.

Entities:  

Mesh:

Year:  1999        PMID: 10491055     DOI: 10.1046/j.1524-4725.1999.98279.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

1.  Laser treatment of pediatric vascular lesions.

Authors:  Patrick D Cole; Michael L Sonabend; Moise L Levy
Journal:  Semin Plast Surg       Date:  2007-08       Impact factor: 2.314

Review 2.  Transcutaneous laser treatment of leg veins.

Authors:  Arne A Meesters; Luiza H U Pitassi; Valeria Campos; Albert Wolkerstorfer; Christine C Dierickx
Journal:  Lasers Med Sci       Date:  2013-11-13       Impact factor: 3.161

3.  A Novel Approach for the Treatment of Spider Veins.

Authors:  Mirsad Mujadzic; Edmond F Ritter; Kenna S Given
Journal:  Aesthet Surg J       Date:  2015-08-04       Impact factor: 4.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.